Overall survival benefit for weekly vs. three-weekly taxanes regimens in advanced breast cancer: A meta-analysis
To access this article, please choose from the options below
PII: S0305-7372(09)00159-5
doi:10.1016/j.ctrv.2009.10.006
© 2009 Elsevier Ltd. All rights reserved.
